$AGN Allergan plc Insider Trading Week 44/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan plc in week 44/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 30 2017 | AGN | Allergan plc | Bailey A Robert D | Chief Legal Officer ... | Option Exercise | M | 0.00 | 7,988 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Bailey A Robert D | Chief Legal Officer ... | Buy | M | 0.00 | 7,988 | 0 | 25,639 | 17.7 K to 25.6 K (+45.26 %) |
Oct 30 2017 | AGN | Allergan plc | Bailey A Robert D | Chief Legal Officer ... | Buy | L | 235.96 | 2 | 472 | 17,651 | 17.6 K to 17.7 K (+0.01 %) |
Oct 30 2017 | AGN | Allergan plc | Bailey A Robert D | Chief Legal Officer ... | Buy | L | 242.21 | 2 | 484 | 12,215 | 12.2 K to 12.2 K (+0.02 %) |
Oct 30 2017 | AGN | Allergan plc | Ling Karen | Chief Human Resourc ... | Option Exercise | M | 0.00 | 7,545 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Ling Karen | Chief Human Resourc ... | Buy | M | 0.00 | 7,545 | 0 | 29,025 | 21.5 K to 29 K (+35.13 %) |
Oct 30 2017 | AGN | Allergan plc | Ling Karen | Chief Human Resourc ... | Buy | L | 235.96 | 4 | 944 | 21,480 | 21.5 K to 21.5 K (+0.02 %) |
Oct 30 2017 | AGN | Allergan plc | Ling Karen | Chief Human Resourc ... | Buy | L | 242.21 | 3 | 727 | 17,882 | 17.9 K to 17.9 K (+0.02 %) |
Oct 30 2017 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Option Exercise | M | 0.00 | 50,599 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | SAUNDERS BRENT L | Chairman, President ... | Buy | M | 0.00 | 50,599 | 0 | 181,777 | 131.2 K to 181.8 K (+38.57 %) |
Oct 30 2017 | AGN | Allergan plc | Meury William | Chief Commercial Of ... | Option Exercise | M | 0.00 | 9,321 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Meury William | Chief Commercial Of ... | Buy | M | 0.00 | 9,321 | 0 | 57,021 | 47.7 K to 57 K (+19.54 %) |
Oct 30 2017 | AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Option Exercise | M | 0.00 | 6,274 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Buy | M | 0.00 | 6,274 | 0 | 19,314 | 13 K to 19.3 K (+48.11 %) |
Oct 30 2017 | AGN | Allergan plc | Stewart Robert A | Chief Operating Off ... | Option Exercise | M | 0.00 | 12,427 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Stewart Robert A | Chief Operating Off ... | Buy | M | 0.00 | 12,427 | 0 | 68,799 | 56.4 K to 68.8 K (+22.04 %) |
Oct 30 2017 | AGN | Allergan plc | Hilado Maria Teresa | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,120 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | Hilado Maria Teresa | Chief Financial Off ... | Buy | M | 0.00 | 7,120 | 0 | 26,810 | 19.7 K to 26.8 K (+36.16 %) |
Oct 30 2017 | AGN | Allergan plc | DArecca James | CHIEF ACCOUNTING OF ... | Option Exercise | M | 0.00 | 799 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | DArecca James | CHIEF ACCOUNTING OF ... | Buy | M | 0.00 | 799 | 0 | 4,322 | 3.5 K to 4.3 K (+22.68 %) |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Option Exercise | M | 0.00 | 37,727 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Buy | M | 0.00 | 37,727 | 0 | 271,774 | 234 K to 271.8 K (+16.12 %) |